MedMen Enterprises (MedMen Enterprises) ROCE % : 0.00% (As of Mar. 2023)

View and export this data going back to 2018. Start your Free Trial

What is MedMen Enterprises ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. MedMen Enterprises's annualized ROCE % for the quarter that ended in Mar. 2023 was 0.00%.

MedMen Enterprises ROCE % Historical Data

The historical data trend for MedMen Enterprises's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMen Enterprises ROCE % Chart

MedMen Enterprises Annual Data

Trend

Oct13

Oct14

Oct15

Oct16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

ROCE %

Get a 7-Day Free Trial

-73.73

-61.49

-94.63

-26.97

-215.93

MedMen Enterprises Quarterly Data
	Apr18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
ROCE %	Get a 7-Day Free Trial															-37.27	-1,536.48	-358.32	-121.64	-

MedMen Enterprises ROCE % Calculation

MedMen Enterprises's annualized ROCE % for the fiscal year that ended in Jun. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2022 )		(A: Jun. 2021 )		(A: Jun. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2022 )		(A: Jun. 2021 )		(A: Jun. 2022 )
	=	-132.378	/	( ( (472.464 - 346.659)	+	(323.224 - 326.417) )	/ 2 )
	=	-132.378	/	( (125.805	+	-3.193)	/ 2 )
	=	-132.378	/	61.306
	=	-215.93 %

MedMen Enterprises's ROCE % of for the quarter that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2023 )		(Q: Dec. 2022 )		(Q: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2023 )		(Q: Dec. 2022 )		(Q: Mar. 2023 )
	=	-99.744	/	( ( (238.475 - 237.644)	+	(215.587 - 474.281) )	/ 2 )
	=	-99.744	/	( ( 0.83099999999999	+	-258.694 )	/ 2 )
	=	-99.744	/	-128.9315
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2023) EBIT data.

MedMen Enterprises (OTCPK:MMNFQ) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

MedMen Enterprises ROCE % Related Terms

Thank you for viewing the detailed overview of MedMen Enterprises's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

MedMen Enterprises (MedMen Enterprises) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MedMen Enterprises Inc (OTCPK:MMNFQ) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

10115 Jefferson Boulevard, Culver City, CA, USA, 90232

Website

https://www.medmen.com

MedMen Enterprises Inc formerly known as Ladera Ventures Corp is the preeminent cannabis company with multiple assets and operations in California, Nevada, and New York, which combined account for nearly half of North America's addressable legal market. The company owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail.